Artios On How To Strike A Deal With Big Pharma
After Merck KGaA And Novartis Pacts
With the number of deals being inked in biopharma continuing apace, the UK firm spoke to Scrip about how to negotiate the line between what big pharma wants and what a biotech is likely to get.
